SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-032119
Filing Date
2022-06-10
Accepted
2022-06-10 08:05:31
Documents
13
Period of Report
2022-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161370-8k_somalogic.htm   iXBRL 8-K 33827
  Complete submission text file 0001213900-22-032119.txt   253130

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE slgc-20220606.xsd EX-101.SCH 3880
3 XBRL DEFINITION FILE slgc-20220606_def.xml EX-101.DEF 27029
4 XBRL LABEL FILE slgc-20220606_lab.xml EX-101.LAB 37250
5 XBRL PRESENTATION FILE slgc-20220606_pre.xml EX-101.PRE 25651
7 EXTRACTED XBRL INSTANCE DOCUMENT ea161370-8k_somalogic_htm.xml XML 5757
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 221007673
SIC: 8731 Services-Commercial Physical & Biological Research